SCHEMBL7159278

SCHEMBL7159278

CCN(CC)CCN(CCN(CC)CC)c1cccc(-c2nc3cnccc3n2C(C)=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.43
TP53 P04637 2/20 0.43
MAPT P10636 2/20 0.43
RAB9A P51151 2/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ATM Q13315 1/20 0.39
HDAC1 Q13547 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
USP2 O75604 1/20 0.36
HTT P42858 1/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
RPS6KA5 O75582 4/20 0.36
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8518781 0.95 NPC1 (0.52) NPC1TP53MAPTRAB9AKDM4E
SCHEMBL7153769 0.92 HDAC1 (0.39) NPC1TP53MAPTRAB9AKDM4E
SCHEMBL7155417 0.87 HDAC1 (0.48) TP53MAPTKDM4EALDH1A1HPGD
SCHEMBL7156031 0.87 MAPT (0.58) NPC1TP53MAPTRAB9AKDM4E
SCHEMBL7155399 0.86 NPC1 (0.60) NPC1TP53MAPTRAB9AKDM4E
SCHEMBL7550136 0.85 RPS6KA5 (0.46) NPC1TP53MAPTRAB9AKDM4E
SCHEMBL8520036 0.84 KDM4E (0.48) NPC1TP53MAPTRAB9AKDM4E
SCHEMBL7159199 0.84 CYP1A2 (0.37) ALDH1A1LMNAHPGDSMN1; SMN2HSD17B10
SCHEMBL8520141 0.83 NPC1 (0.67) NPC1TP53MAPTRAB9AKDM4E
SCHEMBL8518780 0.82 NPC1 (0.44) NPC1TP53MAPTRAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534521-B2 Useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection MILLENNIUM PHARMACEUTICALS, INC. 2003-03-18 US disclosed
US-6348487-B1 ANTIINFLAMMATORY AGENTS, ATHEROSCLEROSIS, RESTINOSIS AND IMMUNE DISORDERS MILLENNIUM PHARMACEUTICALS, INC. 2002-02-19 US disclosed
US-6184235-B1 MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) ANTAGONIST FOR TREATMENT OF INFLAMMATORY DISEASES, ATHEROSCLEROSIS, RESTENOSIS, AUTOIMMUNE DISEASES, ORGAN TRANSPLANT REJECTION IN MAMMALS WARNER-LAMBERT COMPANY 2001-02-06 US disclosed